Mouse Anti-GNG5 Recombinant Antibody (CBLG1-1421) (V2LY-0226-LY186)

Wang, H., Yu, L., Cui, Y., & Huang, J. (2022). G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma. Disease Markers, 2022.

Yuan, Z., Ren, R., & Xu, Z. (2022). G protein subunit gamma 5 promotes the proliferation, metastasis and glycolysis of breast cancer cells through the Wnt/β-catenin pathway. Anti-Cancer Drugs, 33(10), 1004-1011.

Zhang, W., Liu, Z., Liu, B., Jiang, M., Yan, S., Han, X., ... & Lin, Z. (2021). GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma. Cancer cell international, 21(1), 1-20.

Ayo-Martin, A. C., Kyrousi, C., Di Giaimo, R., & Cappello, S. (2020). GNG5 controls the number of apical and basal progenitors and alters neuronal migration during cortical development. Frontiers in Molecular Biosciences, 7, 578137.

Shen, X. F., Cheng, Y., Dong, Q. R., & Zheng, M. Q. (2020). MicroRNA-675-3p regulates IL-1β-stimulated human chondrocyte apoptosis and cartilage degradation by targeting GNG5. Biochemical and Biophysical Research Communications, 527(2), 458-465.

Yang, B., Han, Z. Y., Wang, W. J., Ma, Y. B., & Chu, S. H. (2020). GNG5 is an unfavourable independent prognostic indicator of gliomas. Journal of Cellular and Molecular Medicine, 24(21), 12873-12878.

Hua, X., Chen, J., & Wu, L. (2019). Identification of candidate biomarkers associated with apoptosis in melanosis coli: GNG5, LPAR3, MAPK8, and PSMC6. Bioscience reports, 39(1).

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols